Ann Nutr Metab. 2018;72(1):57-64. doi: 10.1159/000485748. Epub 2017 Dec 22.
Adiponectin, which may have a growth-promoting effect through its insulin-sensitizing action, is thought to play a key role in fetal growth. This study was performed to determine whether maternal and/or cord blood adiponectin concentrations differ between small for gestational age (SGA) and healthy controls.
Databases were searched to identify good quality English language studies providing the number of SGA and healthy controls, and the means and standard deviations of maternal or cord blood adiponectin concentration in both groups. A meta-analysis was performed to summarize the standardized mean differences (SMDs) in maternal and cord blood adiponectin concentrations between SGA and healthy controls.
There was no statistically significant difference in maternal blood adiponectin concentration between SGA and healthy controls (n = 8, p = 0.951). However, cord blood adiponectin concentration was significantly lower in SGA than in healthy controls (n = 6, p = 0.028), and the effect was large (i.e., SMD >0.7).
Maternal blood adiponectin concentration is not low in SGA compared with healthy controls. However, SGA shows lower cord blood adiponectin concentration than healthy controls.
脂联素通过其胰岛素增敏作用可能具有促进生长的作用,被认为在胎儿生长中起关键作用。本研究旨在确定母体和/或脐带血脂联素浓度在小于胎龄儿(SGA)和健康对照组之间是否存在差异。
检索数据库以确定高质量的英文研究,提供 SGA 和健康对照组的数量,以及两组中母体或脐带血脂联素浓度的平均值和标准差。进行荟萃分析以总结 SGA 和健康对照组之间母体和脐带血脂联素浓度的标准化均数差(SMD)。
SGA 和健康对照组之间母体血液脂联素浓度无统计学差异(n=8,p=0.951)。然而,SGA 组的脐带血脂联素浓度明显低于健康对照组(n=6,p=0.028),且效应较大(即 SMD>0.7)。
与健康对照组相比,SGA 患者的母体血液脂联素浓度并不低。然而,SGA 组的脐带血脂联素浓度低于健康对照组。